Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 780 in its research report dated August 14, 2023.
Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 780 in its research report dated August 14, 2023. Motilal Oswal recommended Neutral rating on Glenmark Pharma with a target price of Rs 780 in its research report dated August 14, 2023. Moneycontrol Latest News Read More
